Health & Fitness
Health and Fitness
Health and Fitness
Wed, July 11, 2012Tue, July 10, 2012Mon, July 9, 2012Fri, July 6, 2012Thu, July 5, 2012Wed, July 4, 2012Tue, July 3, 2012Mon, July 2, 2012Sun, July 1, 2012Fri, June 29, 2012Thu, June 28, 2012Wed, June 27, 2012Tue, June 26, 2012Mon, June 25, 2012Sun, June 24, 2012Sat, June 23, 2012Fri, June 22, 2012Thu, June 21, 2012Wed, June 20, 2012Tue, June 19, 2012BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
Published in Health and Fitness on Thursday, June 28th 2012 at 13:42 GMT by Market Wire
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call -- FRANKLIN LAKES, N.J., June 28, 2012 /PRNewswire/ --
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
FRANKLIN LAKES, N.J., June 28, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: [ BDX ]) announced today that it will conduct a live webcast of its third fiscal quarter 2012 earnings conference call on Thursday, August 2, 2012, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning.
The webcast of the conference call, along with related slides, will be accessible through BD's website at [ www.bd.com/investors ] and will be available for replay through Thursday, August 9, 2012.
About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit [ www.bd.com ].
Contact:
Monique N. Dolecki, Investor Relations – 201-847-5378
Colleen T. White, Corporate Communications – 201-847-5369
SOURCE BD (Becton, Dickinson and Company)
[ Back to top ] RELATED LINKS
[ http://www.bd.com ]
